Professional Documents
Culture Documents
02 Pdabrazil Vi Particlelcm Koulov 2fe2024
02 Pdabrazil Vi Particlelcm Koulov 2fe2024
02 Pdabrazil Vi Particlelcm Koulov 2fe2024
Atanas Koulov
Chief Scientific Officer
Clear Solutions Laboratories
atanas.koulov@clearsolutions-labs.com
Fevereiro 2, 2024, 14:00
Prevention
2. Monitoring
a. Periodic or continuous monitoring (action limits)
3. Additional characterization
Connecting People, Science and Regulation®
Particle Control Strategy
1. Control System
a. 100% VI (part of the manufacturing process)
b. Release testing (e.g. AQL)
c. Stability testing
2. Monitoring
a. Periodic or continuous monitoring (action limits)
3. Additional characterization
a. Particle investigations and assessments; facility libraries
● Compendial chapters
(USP<790>/ EP 2.9.20.)
● Compendial methods are considered validated, BUT
suitability for the product needs to be assessed
● Depending on the attributes of the product,
the inspection method can be enhanced
● A multifunctional tool:
○ Define Detectability (PoD) for different particle types/ sizes
○ Qualify inspectors
○ Basis for the design of different test sets
■ introduction/ training
■ testing/ qualification
Connecting People, Science and Regulation®
1a. 100% Visual Inspection -
Inspector qualification
● Training
○ setting up solid training programs is a critical success
factor (see PDA training courses)
● Visual acuity
● Inspector qualification - testing - challenge sets
2. Monitoring
a. Periodic or continuous monitoring (action limits)
3. Additional characterization
a. Particle investigations and assessments; facility libraries
● Additional considerations:
○ Potential intrinsic (typical product-related) particles are
mostly irrelevant
○ How do we qualify inspectors for detecting “inherent”
particles?
○ Expertise:
■ Technical
■ Understanding of pharmaceutical manufacturing
Prevention